written on 02.05.2014

Pfizer's approach may turn hostile after AZ rejects second offer


Pfizer upped its offer for AstraZeneca today from $100 billion to $106 billion, and AstraZeneca dutifully rejected it, but experience in the world of pharma takeovers tells us this is unlikely to be the end of the drama.